Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
ROP
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
seekingalpha.comPOSITIVO
Astera Labs, Salesforce among IT stocks with A+ EPS revision grades
[bad day at wall street] franckreporter As Q3 2026 earnings season approaches, information technology stocks are drawing attention as investors assess earnings expectations across software, hardware, semiconductors, communications equipmen…
Why Roper Technologies (ROP) is Poised to Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Roper Technologies (ROP). This company, which is in the…
Roche Holding (SWX:ROP) Ebola Testing Support Keeps Fair Value In Focus
Roche Holding (SWX:ROP) has been back in focus after Roche Diagnostics shipped two molecular testing instruments to support Ebola response efforts in the Democratic Republic of Congo, tying humanitarian work directly to the diagnostics seg…
What Roper Technologies (ROP)'s AI-Focused Board Addition and Bigger Buybacks Strategy Shift Means For Shareholders
Roper Technologies recently appointed Abhijit Dubey, Chief Executive Officer and Chief AI Officer of NTT DATA, Inc., to its Board of Directors for a term running through the 2027 Annual Meeting of Stockholders, adding deep cloud and artifi…
Roche Holding has delivered a strong multi year share price run, and with the stock last closing at CHF 360.00 the live question is whether that price still lines up with what its earnings support. Recent product milestones and licensing d…
Is Roper Technologies (ROP) Trading At A Discount To Cash Flow?
Roper Technologies has had a rough stretch on the market, which raises a straightforward question for you as an investor: Is the current share price still in line with what the company's cash flows can justify? The stock is down 30.4% over…
Roper Technologies (ROP) Adds AI Expertise On The Board As Fair Value Debate Builds
Board shake-up puts fresh AI expertise on Roper Technologies under investor focus Roper Technologies (ROP) has drawn fresh attention after appointing Abhijit Dubey, Chief Executive Officer and Chief AI Officer of NTT DATA, to its Board of…
Roper (ROP): Are Buybacks a Better Use of Cash than More Acquisitions?
Roper Technologies, Inc. (NASDAQ:ROP) spent $3.2 billion repurchasing shares over three quarters as software acquisition opportunities became harder to justify. Specialized workflows create switching costs, but artificial intelligence is i…
Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC
Roche Diagnostics has provided two molecular testing instruments to Institut National de Santé Publique (INSP) to support Ebola testing capacity in the DRC. Roche will preconfigure the instruments and train local laboratory technicians bef…
Should You Invest in the Invesco Global Water ETF (PIO)?
Designed to provide broad exposure to the Industrials - Water segment of the equity market, the Invesco Global Water ETF (PIO) is a passively managed exchange traded fund launched on June 13, 2007. While an excellent vehicle for long term…
[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Stock index futures were higher on Tuesday, a day after the Nasdaq Composite touched a record high while investors looked ahead to trade data and comments from Federal Rese…
Roper Technologies Looks More Attractive after its Valuation Compression
Roper Technologies, Inc. (NASDAQ:ROP) does not fit the usual image of a technology company. There is no race to win over the biggest consumer audience or become the next major tech platform. Roper has taken a quieter route. The company own…
Should You Invest in the Invesco Water Resources ETF (PHO)?
If you're interested in broad exposure to the Industrials - Water segment of the equity market, look no further than the Invesco Water Resources ETF (PHO), a passively managed exchange traded fund launched on December 6, 2005. An increasin…
3 European Defensive Stocks Investors Are Watching As Bond Markets Turn Risk Off
Bond markets are throwing out fresh stress signals, with investors racing toward German Bunds and dumping riskier debt across Europe. That kind of flight to safety can punish cyclical stocks and fragile balance sheets, yet it can also shin…
What Could Roche Holding (SWX:ROP) Gain From FDA Priority Review In MS?
Roche Holding (SWX:ROP) received FDA acceptance of its New Drug Application for fenebrutinib in multiple sclerosis under priority review. The filing covers fenebrutinib as an oral BTK inhibitor for both relapsing and primary progressive fo…
U.S. Bank and DAT: Contract and spot truck freight rates diverge
Contract rates moved higher through August while spot rates retreated from June levels MINNEAPOLIS, October 01, 2026--(BUSINESS WIRE)--The latest quarterly U.S. Bank Freight Payment Index – Rates Edition showed contract and spot rates foll…
Abhijit Dubey joins Roper Technologies Board of Directors
Roper Technologies, Inc. SARASOTA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that Abhijit Dubey has joined the Company's Board of Directors. Mr. Dubey is Chief Executive Officer and Chief AI O…
Roper Technologies schedules third quarter 2026 financial results conference call
Roper Technologies, Inc. SARASOTA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that its financial results for the third quarter of 2026, ended September 30, 2026, will be released before the mar…
Roche launches newborn screening test for three severe genetic conditions
This test expands Roche's early diagnostics portfolio by screening for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD) simultaneously. Catching these conditions shortly after bi…
CTSH or ROP: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Computers - IT Services sector have probably already heard of Cognizant (CTSH) and Roper Technologies (ROP). But which of these two companies is the best option for those looking for undervalued stoc…
Roche Holding (SWX:ROP) Signed New AI Drug Discovery Partnerships
Roche Holding (SWX:ROP) announced new R&D alliances focused on AI-powered therapeutics and metabolic disease programs in late September 2026. The group signed a research partnership with Earendil Labs to apply AI to bispecific antibody can…
Roche (SWX:ROP) Stock Looks Discounted As Its 60% Run Continues
Roche Holding has delivered a powerful share price run over the last few years, which puts a bright spotlight on whether that market value still lines up with what the group earns. With a string of positive late stage trial results in onco…
Is Roche Holding (SWX:ROP) Undervalued Following Its Phase 3 IgA Nephropathy Win?
Roche Holding (SWX:ROP) is back in focus after partner Ionis reported that sefaxersen met the primary endpoint in the Phase 3 IMAgINATION trial for IgA nephropathy, delivering a statistically significant reduction in proteinuria compared w…
CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis
F. Hoffmann-La Roche Ltd Ocrevus addresses a critical need in paediatric neurology as the first high- efficacy anti-CD20 treatment option for people with MS as young as 10 years old In the Phase III OPERETTA 2 study, Ocrevus demonstrated n…
Roche Holding (SWX:ROP) Phase III Trial Met Its Primary Endpoint In Follicular Lymphoma
Roche Holding (SWX:ROP) reported that its Phase III CELESTIMO trial of Lunsumio plus lenalidomide met its primary endpoint in relapsed or refractory follicular lymphoma. The CELESTIMO data support regulatory submissions to expand Lunsumio'…
ROP Benefits From Strength in Application Software Unit: Can the Momentum Sustain?
Roper Technologies, Inc. ROP is gaining from continued momentum in the Application Software segment. In the second quarter of 2026, ROP's Application Software segment accounted for nearly 56% of Roper's total revenues. The segment revenues…
Roche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO study
F. Hoffmann-La Roche Ltd Phase III CELESTIMO study met its primary endpoint at the interim analysis demonstrating a statistically significant and clinically meaningful reduction in the risk of disease progression in people with follicular…
Illumia Appoints Don Smith to Lead Higher Education Portfolio
New role brings Illumia's higher education commerce, identity and payments businesses under one leader SCOTTSDALE, Ariz., September 15, 2026--(BUSINESS WIRE)--Illumia, a leading provider of technology solutions that power payments, identit…
DAT: Spot van rate falls 20 cents in steepest August pullback on record
DAT Solutions PORTLAND, Ore., Sept. 15, 2026 (GLOBE NEWSWIRE) -- National average truckload spot rates fell across all three equipment types in August, posting the steepest July-to-August declines in DAT's 16-year rate history, according t…
Procare Solutions Acquires Playground, Combining Industry Leading Expertise with Innovative, AI-Powered Child Care Technology
DENVER, Sept. 14, 2026 /PRNewswire/ -- Procare Solutions, a leader in AI-enabled child care management software, trusted by more than 40,000 centers nationwide, announced today it has acquired Playground, a modern, all-in-one child care ma…
Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer
F. Hoffmann-La Roche Ltd Tambotatug pelitecan (Tam-Peli) demonstrated statistically significant efficacy over topotecan in a phase III study conducted in China, reducing the risk of death by 54% and disease progression by 71%, while achiev…
U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments
F. Hoffmann-La Roche Ltd If approved, Enspryng would be the first and only disease-modifying therapy for MOGAD (myelin oligodendrocyte glycoprotein antibody-associated disease) Filing acceptance is based on the Phase III METEOROID study sh…
Roper Technologies In Rebound and a Hot Buy Despite Insider Selling
Key Points Interested in Roper Technologies, Inc.? Here are five stocks we like better. Roper insiders sold shares near depressed summer levels, but the company's Q2 results and guidance increase point to stronger fundamentals. Roper's nic…
These software stocks are in a prime spot to benefit from a rapidly shifting AI landscape
Adobe has an estimated free cash flow yield of 10.57%, compared with an expected FCF yield of only 0.38% for Microsoft, based on consensus 12-month estimates among analysts polled by FactSet. - MarketWatch illustration/iStockphoto, FactSet…
Roper Technologies to present at Piper Sandler Conference
Roper Technologies, Inc. SARASOTA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that it is presenting at the Piper Sandler Growth Frontiers Conference on Tuesday, September 15, 2026, at 8:30 AM…
Stock index futures slide as Middle East tensions keep investors on edge
[Wall Street street sign in Manhattan financial district] Alexey_Fedoren Stock index futures were lower on Tuesday as Middle East tensions remained in focus, with Wall Street set to return after the Labor Day holiday. Dow futures (INDU [ht…